Trial
NCT03004209
Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Autoimmune Encephalitis
Intervention
Erythropoietin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-29